A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
- 1 November 1996
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 348 (9038) , 1329-1339
- https://doi.org/10.1016/s0140-6736(96)09457-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clopidogrel: An Antithrombotic Drug Acting on the ADP-dependent Activation Pathway of Human PlateletsClinical and Applied Thrombosis/hemostasis, 1996
- Aspirin and Other Platelet-Active DrugsChest, 1995
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Clopidogrel, A Novel Antiplatelet and Antithrombotic AgentCardiovascular Drug Reviews, 1993
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958